perifosine has been researched along with erucylphospho-n,n,n-trimethylpropylammonium in 3 studies
| Studies (perifosine) | Trials (perifosine) | Recent Studies (post-2010) (perifosine) | Studies (erucylphospho-n,n,n-trimethylpropylammonium) | Trials (erucylphospho-n,n,n-trimethylpropylammonium) | Recent Studies (post-2010) (erucylphospho-n,n,n-trimethylpropylammonium) |
|---|---|---|---|---|---|
| 245 | 31 | 140 | 36 | 0 | 24 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, MR; Konstantinov, SM; Reufsteck, C; Yosifov, DY | 1 |
| van Blitterswijk, WJ; Verheij, M | 1 |
| Gaillard, B; Lebeau, L; Pons, F; Remy, JS | 1 |
1 review(s) available for perifosine and erucylphospho-n,n,n-trimethylpropylammonium
| Article | Year |
|---|---|
Anticancer mechanisms and clinical application of alkylphospholipids.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Membrane; Endocytosis; Humans; Neoplasms; Organophosphates; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phospholipid Ethers; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quaternary Ammonium Compounds; Signal Transduction | 2013 |
2 other study(ies) available for perifosine and erucylphospho-n,n,n-trimethylpropylammonium
| Article | Year |
|---|---|
Interleukin-6, osteopontin and Raf/MEK/ERK signaling modulate the sensitivity of human myeloma cells to alkylphosphocholines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; MAP Kinase Signaling System; Multiple Myeloma; Organophosphates; Osteopontin; Phosphorylcholine; Proto-Oncogene Proteins c-raf; Quaternary Ammonium Compounds; Signal Transduction; Treatment Outcome | 2012 |
Synthesis and Evaluation of Antitumor Alkylphospholipid Prodrugs.
Topics: Administration, Intravenous; Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Stability; Hemolysis; Humans; Maximum Tolerated Dose; Neoplasms; Organophosphates; Phosphorylcholine; Prodrugs; Quaternary Ammonium Compounds | 2020 |